Prothymosin alpha pseudogene 9 (PTMAP9)

Prothymosin alpha pseudogene 9 (PTMAP9) is a processed pseudogene in the human prothymosin alpha gene family. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from duplication or retrotransposition events. The prothymosin alpha gene family has one functional gene (PTMA) and several processed pseudogenes, including PTMAP9, which do not encode functional proteins. There is no evidence for the expression or therapeutic relevance of this pseudogene, nor any established role in cellular processes or disease. The only functional member of this gene family is PTMA; all other family members, including PTMAP9, are considered inactive and not therapeutic targets[1]. Key notes and reasoning: - PTMAP9 is identified as a processed pseudogene based on genomic analysis of the prothymosin alpha family, where only PTMA is functional; PTMAP9 does not produce a protein product and has no confirmed biological role[1]. - Prothymosin alpha (PTMA, the parent gene) is associated with various immune and cellular functions, but pseudogenes such as PTMAP9 lack these properties[1][3]. - No aliases, drugs, mechanisms of action, biomarkers, or safety concerns are recorded for PTMAP9, as it is not a functional gene or a validated biomedical target. - The "is_incorrect" flag is set to "true" because PTMAP9 is not a protein, not an expressed gene, and not a target suitable for therapeutic modulation. Summary judgement: PTMAP9 is a non-coding, non-functional pseudogene and not a therapeutic target; information about therapeutic targeting, molecular function, or drugs does not apply[1].

Other names

PTMAP9